Safety and Efficacy Results From iSABR, a Phase 1 Study of Stereotactic ABlative Radiotherapy in Combination With Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer
Related Posts
Rubenstein LV, Newberry SJ, Ghai I, Motala A, Curtis I, Shekelle PG, Wagner TH, Tran LD, Fihn SD, Nelson KM. Measuring Primary Care Productivity in[...]
Prescription Drug Utilization and Spending by Race, Ethnicity, Payer, Health Condition, and US State
Sahu M, Wagner TD, Thomson A, Beauchamp M, Campbell JD, Crosby S, DeJarnatt D, Lescinsky H, Salih RK, Taylor K, Weil M, Dwyer-Lindgren L, Haakenstad[...]
Norris KC, Mohottige D. A Scientific Approach to the Use of Racial and Ethnic Identities in Medicine and Kidney Health. Clin J Am Soc Nephrol.[...]